Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schulz-Key

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|October 20, 1984
Ivermectin in onchocerciasisK Awadzi, K Y Dadzie, H Schulz-Key, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2001
Detection of the acute phase of abdominal angiostrongyliasis with a parasite-specific IgG enzyme linked immunosorbent assayS M Geiger, A C Laitano, C Sievers-Tostes, et al.
Parasitology Research|May 17, 2003
Angiostrongylus costaricensis infection in C57BL/6 mice: MHC-II deficiency results in increased larval elimination but unaltered mortalityS M Geiger, W H Hoffmann, P T Soboslay, et al.
Clinical and Experimental Immunology|February 17, 2007
Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapyC S Mai, D M Hamm, M Banla, et al.
Tropical Medicine & International Health : TM & IH|July 1, 1997
Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kDW H Hoffmann, C H Blanke, J M Maier, et al.
Experimental Parasitology|June 1, 1992
Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulusP T Soboslay, N Weiss, C M Dreweck, et al.
Parasitology|November 26, 2003
Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection in offspring: an 18 year follow-up studyA K Kirch, H P Duerr, B Boatin, et al.
Clinical and Experimental Immunology|October 20, 2005
Chemokines in onchocerciasis patients after a single dose of ivermectinJ Fendt, D M Hamm, M Banla, et al.
Clinical and Experimental Immunology|July 15, 1999
Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothersP T Soboslay, S M Geiger, B Drabner, et al.
Immunology|August 14, 1999
Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controlsP T Soboslay, C G Lüder, S Riesch, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|October 20, 1984
Ivermectin in onchocerciasisK Awadzi, K Y Dadzie, H Schulz-Key, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2001
Detection of the acute phase of abdominal angiostrongyliasis with a parasite-specific IgG enzyme linked immunosorbent assayS M Geiger, A C Laitano, C Sievers-Tostes, et al.
Parasitology Research|May 17, 2003
Angiostrongylus costaricensis infection in C57BL/6 mice: MHC-II deficiency results in increased larval elimination but unaltered mortalityS M Geiger, W H Hoffmann, P T Soboslay, et al.
Clinical and Experimental Immunology|February 17, 2007
Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapyC S Mai, D M Hamm, M Banla, et al.
Tropical Medicine & International Health : TM & IH|July 1, 1997
Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kDW H Hoffmann, C H Blanke, J M Maier, et al.
Experimental Parasitology|June 1, 1992
Experimental onchocerciasis in chimpanzees. Antibody response and antigen recognition after primary infection with Onchocerca volvulusP T Soboslay, N Weiss, C M Dreweck, et al.
Parasitology|November 26, 2003
Impact of parental onchocerciasis and intensity of transmission on development and persistence of Onchocerca volvulus infection in offspring: an 18 year follow-up studyA K Kirch, H P Duerr, B Boatin, et al.
Clinical and Experimental Immunology|October 20, 2005
Chemokines in onchocerciasis patients after a single dose of ivermectinJ Fendt, D M Hamm, M Banla, et al.
Clinical and Experimental Immunology|July 15, 1999
Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothersP T Soboslay, S M Geiger, B Drabner, et al.
Immunology|August 14, 1999
Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controlsP T Soboslay, C G Lüder, S Riesch, et al.
Pageof 8